IKAROS binding at the MTOR promoter was determined by a quantitative chromatin immunoprecipitation (qChIP) assay of primary B-ALL cells (Fig. 1c), and B-ALL cell lines (Fig. S2). Here, IKZF1 is linked to acute lymphoblastic leukemia.